Cart
sales@molnova.com
Reglitazar
CAS No. 170861-63-9
Reglitazar( —— )
Catalog No. M34392 CAS No. 170861-63-9
Reglitazar (JTT-501) is a dual PPARα and PPARγ agonist that is used to study diabetes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 445 | Get Quote |
|
| 5MG | 686 | Get Quote |
|
| 10MG | 938 | Get Quote |
|
| 25MG | 1398 | Get Quote |
|
| 50MG | 1822 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameReglitazar
-
NoteResearch use only, not for human use.
-
Brief DescriptionReglitazar (JTT-501) is a dual PPARα and PPARγ agonist that is used to study diabetes.
-
DescriptionReglitazar (JTT-501) is a dual PPARα and PPARγ agonist that is used to study diabetes.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorPPAR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number170861-63-9
-
Formula Weight392.4
-
Molecular FormulaC22H20N2O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1ONC(=O)C1CC2=CC=C(OCCC=3N=C(OC3C)C=4C=CC=CC4)C=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Dauricine
Dauricine has pulmonary toxicity, can produce pulmonary injury in CD-1 mice by the metabolism of Dauricine mediated by CYP3A.
-
(±)4-HDHA
(±)4-HDHA (4-Hydroxy docosahexaenoic acid) is a PPARγ agonist with anti-inflammatory activity that directly inhibits endothelial cell proliferation and sprouting angiogenesis via PPARγ, which can be used in the study of diabetes.
-
4'-Methoxychalcone
4'-Methoxychalcone with a variety of pharmacological activities such as anti-tumor and anti-inflammatory activities.
